Medical Marijuana, Inc. announced that its subsidiary Kannaway has been granted Russia’s first-ever certificate to legally import cannabidiol (CBD) products into the country.
According to the certificate, Kannaway “is the first company in the Russian Federation to have cannabidiol in its products.” This certification allows Kannaway to import its wide range of CBD products into the country, including the Company’s popular tinctures, oils, skincare products and more.
“We have achieved a huge milestone for both Kannaway and Russia with this certificate,” said Kannaway CEO Blake Schroeder. “No other CBD products have legally been imported and sold to Russian consumers. This presents a unique opportunity for us to share the global buzz about the potential benefits CBD can offer and help people in Russia incorporate it into their everyday lives.”
In recent months, Kannaway has been expanding greatly in both Asia and Europe. Europe has quickly become the Company’s largest market since the inception of operations on the continent in 2018 and in late 2019 the Company announced that it is starting to offer its products throughout Asia. So far this year, the Company has also expanded into Kazakhstan and Kyrgyzstan.
“We are not strangers to being the first company to import CBD into a country as we were the first in several others including Mexico, Brazil, Paraguay, and Bulgaria,” said Dr. Stuart Titus, CEO of Medical Marijuana, Inc. “When entering a new market, it’s important to prioritize education and set quality product standards for others to follow and create a safe supply chain for all.”
Kannaway is a network sales and marketing company specializing in the sales and marketing of hemp-based botanical products.
Medical Marijuana, Inc. is the first-ever publicly traded cannabis company in the United States that launched the world’s first-ever cannabis-derived nutraceutical products, brands, and supply chain.